Skip to Main Content

Ingredient | Tone and Tyrosinase

Kojic Acid

INCI · Kojic Acid

Related names and forms: . This list does not indicate synonyms or exact ingredient matches.

Kojic acid (INCI: Kojic Acid; CID 3840, chemical formula C6H6O4, CAS 501-30-4) takes its name from koji, a fermentation culture central to Japanese cuisine. It was first identified as a by-product of fungi such as Aspergillus oryzae involved in rice or soy fermentation. Its cosmetic interest comes from its relationship with tyrosinase, a key enzyme in pigment (melanin) formation. Kojic acid interacts with the copper ion at the enzyme's active site and is considered in relation to slowing its action, leading to its use in tone and dark spot-appearance messaging. Its tendency to bind metal ions (chelation) also gives it a mild antioxidant and stabilising aspect. An important limit: kojic acid in a cosmetic product is not a treatment. Its role concerns cosmetic appearance in even-tone and dark spot-prone profiles. A clinical pigmentation condition such as melasma is assessed with a specialist, not through an ingredient. For stability, pure kojic acid can darken over time with light and air, so protective packaging and pairing with tone ingredients such as arbutin, niacinamide or vitamin C are often preferred. Some skin may feel irritated, particularly with high concentrations and multiple layered actives. Regulatory authorities (EU SCCS) have assessed concentrations for cosmetic use. Klaris considers kojic acid with restraint, alongside concentration, the whole formula and your Skin Identity, not as a miraculous dark spot remover.

Klaris Ingredient GuidePlate 083128Antioxidants1% - 2% (typical in a cosmetic context)Last Updated:

i. Cosmetic Functions

Frequently Discussed Effects

The following headings summarise areas of effect frequently discussed in the literature; visible results in each area require regular use and a suitable formula.

  • Tone and Dark Spot Appearance

    Frequently discussed for even-looking tone and dark spot-prone skin in the context of the appearance of pigment balance.

  • Tyrosinase Context

    Associated with targeting tyrosinase, an enzyme involved in melanin production, through interaction with copper ions.

  • Antioxidant and Chelating Aspects

    Its tendency to bind metal ions (chelation) is also discussed in a mild antioxidant context.

Mechanism

What Happens Within the Skin?

The following points summarise mechanisms from dermocosmetic literature in plain English. Klaris presents them as background information to help readers understand the context, not as medical claims.

  1. Step 1

    A Small Molecule from Fungi

    A defined small molecule produced by fungi involved in koji fermentation (CID 3840).

  2. Step 2

    Tyrosinase and Copper Interaction

    Interacts with the copper-containing active site of tyrosinase, an enzyme involved in pigment production, and is considered in relation to slowing melanin formation.

  3. Step 3

    Appearance, Not Treatment

    Its effect concerns cosmetic tone and dark spot appearance. A clinical pigmentation condition calls for specialist assessment.

ii. Role in the Formula

How Is It Read on a Label?

Kojic acid (CID 3840, C6H6O4, CAS 501-30-4) is a small molecule produced by fungi, particularly in Aspergillus or koji fermentation. In cosmetics, it appears in serums, creams and targeted care marketed for tone and dark spot appearance. It is considered in relation to slowing pigment formation by interacting with copper at the active site of tyrosinase. In pure form, it can darken over time with light and air, a stability limitation. Protective packaging and frequent pairing with niacinamide, arbutin or vitamin C are therefore preferred in formulation.

Typical Concentration Range

1% - 2% (typical in a cosmetic context)

Ingredient Family

Antioxidants

iii. Sensitivity Advisory

A Note on Extra Care in Context

Kojic acid may cause an irritated feeling in some sensitive profiles, requiring extra caution particularly at high concentrations or when layered with other actives. Regulatory authorities (EU SCCS) have assessed concentrations for cosmetic use; the labelled percentage and whole formula are considered in context. A clinical dark spot or pigmentation condition is assessed with a specialist, not through a cosmetic ingredient.

A sensitivity advisory is not an instruction for use; where individual health circumstances, pregnancy or known sensitivities are involved, discussing the decision with your doctor may be a more contextual approach.

Scientific Basis

Sources and Their Scope

The following headings indicate areas of research; they are not citations of a specific publication or confirmation that every statement on this page has been verified. The links provided should be read with their individual scope in mind.

  • International INCI / CosIng database
  • Dermocosmetic research publications
  • Regulatory authority documents (EU SCCS, TİTCK)

TİTCK, SCCS and similar regulatory authorities are mentioned in the context of publicly available regulation; Klaris has no official endorsement, partnership or collaboration with these institutions.

Last Updated: · Klaris Editorial

Klaris · Example Analyses

How Does Kojic Acid Feature in Your Products?

Explore product examples to see the ingredient list, general assessment and match score that changes with the example profile together.

Masked products and example profiles, not a personal analysis. Profile matching in the app is part of Klaris Premium. The app is currently available in Turkish. An English version is in preparation.

Subscribe to the Newsletter

This page is for information only; it does not replace a medical diagnosis, treatment or a statement of individual suitability. If you have sensitivities, are pregnant or have particular circumstances, you are advised to discuss your decisions with your own doctor.